Palantir CEO drops 11-word bombshell for stock market investors
Software stocks have had a rough year. The fear driving them down is real: AI agents are getting good enough […]
Featured
Financial Silence Hurts Your Wealth: How to Break the Cycle
Financial conversations can be difficult and uncomfortable, leading many Americans to neglect them altogether. Whether it’s debt, retirement, investing or
Stock Market Today: Dow Down After Surprise Jobs Reading; Cloudflare Soars
The Dow Jones Industrial Average and other major stock indexes started mixed Friday, with the U.S. July jobs report unexpectedly
3 Signs Medicare Advantage Might Not Be for You
Signing up for Medicare isn’t as clear-cut a process as some might think. That’s because enrollees have a big decision
Mortgage Rates Today, Friday, August 7: Higher for Now
Mortgage rates are a little higher this morning, but are likely to soften on the heels of a lackluster jobs
Ask the Tax Editor: Is it a Hobby or a Business?
Each week in our Ask the Editor series, Joy Taylor, The Kiplinger Tax Letter editor, answers questions on topics submitted
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Aug. 7 1. Futures rose after nonfarm payrolls unexpectedly fell 23,000 in July.
Palantir CEO drops 11-word bombshell for stock market investors
Software stocks have had a rough year. The fear driving them down is real: AI agents are getting good enough
Rathbones Dividend Yield Reveals a Wealth Manager Worth Examining for Income
The Rathbones dividend yield sits at approximately 4.8% on a trailing basis, according to Simply Wall St, sitting above the
INmune Bio Inc. (INMB) Q2 2026 Earnings Call Transcript
Operator Welcome to INmune Bio’s Second Quarter 2026 Earnings Call. [Operator Instructions] As a reminder, this conference call is being